| Primary |
| Pain |
43.8% |
| Fibromyalgia |
12.5% |
| Insomnia |
12.5% |
| Prophylaxis Of Neural Tube Defect |
12.5% |
| Depression |
6.3% |
| Neuralgia |
6.3% |
| Product Used For Unknown Indication |
6.3% |
|
| Pyrexia |
28.6% |
| Torticollis |
28.6% |
| Dry Mouth |
14.3% |
| Sinusitis |
14.3% |
| Ventricular Dyskinesia |
14.3% |
|
| Secondary |
| Bipolar Disorder |
36.4% |
| Product Used For Unknown Indication |
19.9% |
| Pain |
7.3% |
| Back Pain |
5.3% |
| Chronic Obstructive Pulmonary Disease |
5.3% |
| Depression |
4.0% |
| Hypertension |
3.3% |
| Migraine |
3.3% |
| Nutritional Supplementation |
2.0% |
| Anxiety |
1.3% |
| Diabetes Mellitus |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Glaucoma |
1.3% |
| Glioma |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Neuralgia |
1.3% |
| Prophylaxis Of Neural Tube Defect |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Androgen Deficiency |
0.7% |
| Antidepressant Therapy |
0.7% |
|
| Speech Disorder |
21.4% |
| Suicide Attempt |
10.7% |
| Sinusitis |
7.1% |
| Suicidal Ideation |
7.1% |
| Completed Suicide |
3.6% |
| Drug Interaction |
3.6% |
| Dysuria |
3.6% |
| Exposure During Pregnancy |
3.6% |
| Hyponatraemia |
3.6% |
| Nephrogenic Diabetes Insipidus |
3.6% |
| Overdose |
3.6% |
| Poisoning |
3.6% |
| Pregnancy |
3.6% |
| Torticollis |
3.6% |
| Urinary Incontinence |
3.6% |
| Urinary Retention |
3.6% |
| Ventricular Dyskinesia |
3.6% |
| Ventricular Septal Defect |
3.6% |
| Wrong Drug Administered |
3.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
49.5% |
| Pain |
7.5% |
| Rheumatoid Arthritis |
5.3% |
| Hypertension |
4.6% |
| Prophylaxis |
4.1% |
| Depression |
3.2% |
| Hepatitis C |
2.8% |
| Psoriatic Arthropathy |
2.6% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Arthritis |
2.4% |
| Infection Prophylaxis |
2.2% |
| Multiple Sclerosis |
2.1% |
| Drug Use For Unknown Indication |
1.9% |
| Prophylaxis Of Nausea And Vomiting |
1.5% |
| Psoriasis |
1.5% |
| Migraine |
1.4% |
| Asthma |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Fibromyalgia |
1.2% |
| Osteoarthritis |
1.2% |
|
| Sinusitis |
8.0% |
| Vomiting |
8.0% |
| Injection Site Pain |
6.8% |
| Myocardial Infarction |
6.8% |
| Pain |
6.8% |
| Paraesthesia |
5.7% |
| Weight Increased |
5.7% |
| White Blood Cell Count Decreased |
5.7% |
| Rash |
4.5% |
| Rhabdomyolysis |
4.5% |
| Transient Ischaemic Attack |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
| Urinary Tract Infection |
4.5% |
| Death |
3.4% |
| Depression |
3.4% |
| Drug Effect Decreased |
3.4% |
| Drug Ineffective |
3.4% |
| Headache |
3.4% |
| Injection Site Reaction |
3.4% |
| Injection Site Swelling |
3.4% |
|
| Interacting |
|
| Potentiating Drug Interaction |
66.7% |
| Drug Interaction |
33.3% |
|
